| Analysis | Metabolite Name | Measured Value | Units | subject type |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 3438 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Healthy control | |
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Mild disease | |
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Severe disease | |
| Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1418 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Healthy control | |
| Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Mild disease | |
| Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Severe disease |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|